Device Trial Radar · NCT03348761
rTMS Response Trajectories in Depression
Last checked: Nov 19, 2026Latest source record: Feb 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Aug 4, 2015
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Chinese University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 21, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Notwithstanding the cumulative evidence on the safety and efficacy of transcranial magnetic stimulation in depression care, the non-response rate to transcranial magnetic stimulation (TMS) amongst treatment-resistant depression has remained substantial despite the health care cost and time incurred. There remains a compelling clinical need to find valid biomarkers to inform personalized treatment. Using supervised machine learning on 4 combined features of neuroimaging markers, our group recently reported excellent prediction for clinical response in 70 patients receiving TMS to left dorsolateral prefrontal cortex for medication-resistant major depression in 2015-18 (Phase 1 study).The clinical utility of these potential neuroimaging biomarkers is still uncertain without further validation of the trained model in an independent clinical cohort.
Conditions
- Depression
Interventions
rTMS groupDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Ashberg Depression Rating ScaleTime frame: Percentage change baseline versus week 4
- Montgomery-Ashberg Depression Rating ScaleTime frame: Percentage change baseline versus week 6
- Montgomery-Ashberg Depression Rating ScaleTime frame: Percentage change baseline versus week 8
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Psychiatry, CUHK
Hong Kong, Hong Kong · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.